Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Common stock, par value $0.00001 · CUSIP: 15117F880
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 1,109.00 · Class: 0.06%
- Wilmot B. Harkey
Shares: 1,109.00 · Class: 0.06%
- Daniel Mack
Shares: 1,109.00 · Class: 0.06%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-078706
- Form type
- SCHEDULE 13G/A
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership